HCW Biologics Inc (HCWB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.73M
Last updated: Nov 17, 2026 at 10:58 AM ET
HCW Biologics Inc (HCWB) Stock Forecast
Analysts expect HCW Biologics (HCWB) to earn -$28.32 per share in the fiscal year ending Dec 31, 2026, on revenue of $6.68M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$6.30.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$28.32
- EPS consensus, revenue $6.68M
- Fiscal year ending Dec 31, 2027
- -$6.30
- EPS consensus
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$28.32 | -$28.32 to -$28.32 | 1 | $6.68M | $6.68M to $6.68M | 1 |
| Dec 31, 2027 | -$6.30 | -$6.30 to -$6.30 | 1 | N/A | N/A | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.42 | N/A | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$2.88.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$28.32 | -$2.88 | -$2.88 | -$2.88 | -$2.88 | N/A |
| Fiscal year ending Dec 31, 2027 | -$6.30 | -$2.64 | -$2.64 | -$2.64 | -$2.64 | N/A |
Frequently Asked Questions About HCWB
What is the HCWB stock forecast?
Consensus analyst estimates put HCW Biologics's EPS at -$28.32 for the fiscal year ending Dec 31, 2026, on revenue of $6.68M.
What EPS do analysts expect from HCWB next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$28.32, with estimates from -$28.32 to -$28.32 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$6.30, with estimates from -$6.30 to -$6.30 from 1 analyst.
What revenue do analysts expect from HCW Biologics next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $6.68M, with estimates from $6.68M to $6.68M.
How many analysts cover HCWB?
1 analyst estimates EPS for HCW Biologics for the fiscal year ending Dec 31, 2026.
HCWB pages: Overview, Earnings, Forecast, Financials, Competitors